XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share

4. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2023 and 2022 (in thousands, except per share amounts):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to Acadia Healthcare Company, Inc.

 

$

(217,710

)

 

$

71,099

 

 

$

(79,396

)

 

$

212,015

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding for basic earnings per share

 

 

91,168

 

 

 

89,833

 

 

 

90,852

 

 

 

89,607

 

Effects of dilutive instruments

 

 

 

 

 

1,890

 

 

 

 

 

 

2,061

 

Shares used in computing diluted earnings per common share

 

 

91,168

 

 

 

91,723

 

 

 

90,852

 

 

 

91,668

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) earnings per share attributable to Acadia Healthcare
     Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(2.39

)

 

$

0.79

 

 

$

(0.87

)

 

$

2.37

 

Diluted

 

$

(2.39

)

 

$

0.78

 

 

$

(0.87

)

 

$

2.31

 

 

For the three and nine months ended September 30, 2023, approximately 0.5 million and 0.8 million, respectively, outstanding shares of restricted stock and shares of common stock issuable upon exercise of outstanding stock option awards have been included in the calculation of weighted-average shares outstanding-diluted. These shares are excluded from the calculation of diluted earnings per share in the condensed consolidated statement of operations because the net loss for both the three and nine months ended September 30, 2023 causes such securities to be anti-dilutive. Approximately 0.4 million shares of common stock issuable upon exercise of outstanding stock option awards were excluded from the calculation of diluted earnings per share for both the three and nine months ended September 30, 2023, respectively, because their effect would have been anti-dilutive. Approximately 0.1 million and 0.6 million shares of common stock issuable upon exercise of outstanding stock option awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2022, respectively, because their effect would have been anti-dilutive.